Xcout Intel
Benchling
Benchling, Inc. is a Delaware corporation located in San Francisco, California, providing a life sciences R&D cloud software platform.
Subscribe to see Benchling’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Benchling at a glance
Benchling is a healthtech company headquartered in United States. It has raised at least $27.4M across the 5 funding rounds on record, 4 of them with a disclosed amount. Its most recent funding round, Series E, closed in April 2021. Xcout recorded 100 job postings from Benchling in the last 90 days, naming tools such as Salesforce, NetSuite, Jira.
Benchling funding rounds
At least $27.4M raised across the 5 rounds on record (4 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series E | Undisclosed | — | |
| Series B | $14.5M | — | |
| SEC Form D filing | $7M | — | |
| Seed | $5M | — | |
| Seed | $900,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Benchling
Xcout recorded 100 job postings from Benchling in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Benchling's job postings
The weekly hiring trend, the roles and locations behind it and all 13 tools — see Benchling's hiring signals →
Hiring vs the trend
Based on 51 job postings in the last 8 weeks (24 Aug – 18 Oct 2026), compared with 266 startup technology companies.
This describes a hiring pattern — how often Benchling’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Benchling competitors
A few of Benchling's closest competitors — see the full list of competitors and alternatives →
Ginkgo Bioworks is a biotechnology research company headquartered in Boston, Massachusetts, that provides autonomous lab platforms for automated biological experiments.
Riffyn, Inc. is a California-based software solution provider that offers research and development applications for managing and exporting experiment data sets.
Synthace provides software that helps life science researchers design, run, and analyze high-dimensional biological experiments. Headquartered in London at the WestWorks building, the company focuses on delivering AI-ready data.
DeepCyte Inc. is an AI-powered biotechnology and toxicology platform headquartered in Wilmington, Delaware. Established in 2025, the company develops advanced computational tools for toxicity assessment and life sciences research.
Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.
Tamarind Bio, Inc. provides AI infrastructure for biotech R&D, offering top computational biology tools to design and score proteins, peptides, and small molecules. Headquartered in San Francisco, California, the platform aims to accelerate discovery and research in the life sciences sector.
Get Benchling's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Benchling? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Benchling in Xcout Intel
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access